REGN logo

Regeneron Pharmaceuticals, Inc.

REGN
0.00
USD
+0.00+0.00%

Regeneron Pharmaceuticals, Inc. at a glance

Open REGN on Vela

Regeneron Pharmaceuticals, Inc. (REGN) is a Healthcare company in the Biotechnology industry, headquartered in Tarrytown, NY, with about 15,410 employees. Its shares trade on NASDAQ, and its IPO date is April 2, 1991. With a market capitalization of $80.2 billion, REGN is a large-cap stock.

It trades an average of 811,190 shares a day.

In its latest reported quarter (results released July 30, 2026), Regeneron Pharmaceuticals, Inc. posted revenue of $4.3 billion and earnings of $14.29 per share, against estimates of $3.8 billion and $10.16.

Figures as of October 14, 2026, from market data providers. Descriptive only, not financial advice.

REGN: Frequently asked questions

As of October 14, 2026, Regeneron Pharmaceuticals, Inc. has a market capitalization of $80.2 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.